When the VITAL-2 study was terminated, the IDMC reported an imbalance in deaths between the 2 treatment groups that was observed during a routine safety-monitoring meeting of the committee.

• 当VITAL-2 研究终止时，IDMC报告指出，在该委员会的常规安全监控会议中观察发现，两个治疗组之间的死亡件数差异很大。